MedPath
HSA Approval

LUFI-500 TABLET 500mg

SIN14808P

LUFI-500 TABLET 500mg

LUFI-500 TABLET 500mg

July 15, 2015

ZYFAS PHARMA PTE LTD

ZYFAS PHARMA PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantZYFAS PHARMA PTE LTD
Licence HolderZYFAS PHARMA PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

J01MA12

levofloxacin

Manufacturer Information

ZYFAS PHARMA PTE. LTD.

Ipca Laboratories Limited

Active Ingredients

Levofloxacin hemihydrate. 518.52 mg equivalent to Levofloxacin

500mg

Levofloxacin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.